Skip to main content
Clinical Trials/NCT01147757
NCT01147757
Unknown
N/A

Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic Ureteroneocystostomy

Yonsei University1 site in 1 country60 target enrollmentJune 2010
ConditionsPediatrics
Interventionsremifentanil

Overview

Phase
N/A
Intervention
remifentanil
Conditions
Pediatrics
Sponsor
Yonsei University
Enrollment
60
Locations
1
Primary Endpoint
fentanyl consumption for IV-PCA
Last Updated
14 years ago

Overview

Brief Summary

Effect of intraoperative remifentanil infusion rate on postoperative tolerance and analgesic consumption in pediatric laparoscopic ureteroneocystostomy.

Registry
clinicaltrials.gov
Start Date
June 2010
End Date
June 2012
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jeong-Yeon Hong

associate professor

Yonsei University

Eligibility Criteria

Inclusion Criteria

  • Pediatric patients (ASA physical status I and II) aged between 1-5 yrs and scheduled elective laparoscopic ureteroneocystostomy

Exclusion Criteria

  • cardiovascular, renal, liver disease or growth retardation

Arms & Interventions

remifentanil 0.6 mcg/kg/min

Group 0.6 (n = 15): remifentanil 0.6 mcg/kg/min

Intervention: remifentanil

saline

Group S (n = 15): saline

Intervention: remifentanil

remifentanil 0.3 mcg/kg/min

Group 0.3 (n = 15): remifentanil 0.3 mcg/kg/min

Intervention: remifentanil

remifentanil 0.9 mcg/kg/min

Group 0.9 (n = 15): remifentanil 0.9 mcg/kg/min

Intervention: remifentanil

Outcomes

Primary Outcomes

fentanyl consumption for IV-PCA

Time Frame: 24 h and 48 h after surgery

Postoperative pain score

Time Frame: during 48 h after surgery

Study Sites (1)

Loading locations...

Similar Trials